Even with new competition, Botox can hold its own in growing migraine field: Allergan executives
Ready for Botox, millennials? Allergan has launched its first campaign targeting you
«Πόρτα» σε Novartis για το Aimovig κατά της ημικρανίας από τον NICE
Allergan adds actor Scott Eastwood to Alzheimer's effort for even more celebrity firepower
OnabotulinumtoxinA (Botox, Allergan) treatment is more effective, is better tolerated, and has greater functional improvement in the prevention of chronic migraine compared with the anticonvulsant topiramate, new research suggests. In a 36-week head-to-head, prospective, open-label study, investigators found a greater proportion of patients in the onabotulinumtoxinA group (40%) achieved the primary outcome of a … Συνεχίστε να διαβάζετε Botox Tops Topiramate for Chronic Migraine Prevention.
While Humira held its ad spending crown yet again in May, Latuda jumped up to knock Lyrica from the No. 2 spot it's held for the past few months. Sunovion started revving up its Latuda outlays in April, but jacked up spending by 67% in May, according to data from real-time TV ad tracker iSpot.tv. What's … Συνεχίστε να διαβάζετε In May TV spending, Sunovion jumps to 2nd, but AbbVie easily keeps top spot.